I am a
Home I AM A Search Login

Papers of the Week


2021 Jul 23


EBioMedicine


70

SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.

Authors

Chen H, Liu W, Wang Y, Liu D, Zhao L, Yu J
EBioMedicine. 2021 Jul 23; 70:103500.
PMID: 34311326.

Abstract

The outbreak of Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection has become a global health emergency. We aim to decipher SARS-CoV-2 infected cell types, the consequent host immune response and their interplay in lung of COVID-19 patients.